Medication-associated lesions of the GI tract

Gastrointestinal Endoscopy

Volumn 79, Issue 1, 2014, Pages 140-150

  Seminerio, Jennifer ^a   McGrath, Kevin ^a   Arnold, Christina A ^b   Voltaggio, Lysandra ^c   Singhi, Aatur D ^d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

COX; cyclooxygenase; MMF; mycophenolate mofetil; nonsteroidal anti inflammatory drug; NSAID

Indexed keywords

ALENDRONIC ACID; ANTINEOPLASTIC AGENT; BEVACIZUMAB; BLEOMYCIN; CENTRAL DEPRESSANT AGENT; CLINDAMYCIN; COLCHICINE; COLESTYRAMINE; CORTICOSTEROID; CYTARABINE; DACTINOMYCIN; DAUNORUBICIN; DOXYCYCLINE; ETIDRONIC ACID; FERROUS SULFATE; FLUOROURACIL; IPILIMUMAB; IRON; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; OLMESARTAN; PACLITAXEL; PAMIDRONIC ACID; POLYSTYRENESULFONATE SODIUM; POTASSIUM CHLORIDE; QUINIDINE; SEVELAMER CARBONATE; UNINDEXED DRUG; VINCRISTINE; ANION EXCHANGE RESIN; ANTIBIOTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CHLORIDE ION; MONOCLONAL ANTIBODY; RESIN; SUCRALFATE; TETRACYCLINE DERIVATIVE;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ANASTOMOSIS LEAKAGE; BLEEDING; CELIAC DISEASE; CHEMICAL BURN; COLITIS; COLON BIOPSY; COLON INJURY; COLON PERFORATION; COUGHING; DIAPHRAGM DISEASE; DIARRHEA; DIGESTIVE SYSTEM INJURY; DRUG INDUCED DISEASE; DYSPHAGIA; ENTEROCOLITIS; ESOPHAGITIS; ESOPHAGUS BIOPSY; ESOPHAGUS INJURY; GASTRITIS; GASTROINTESTINAL TOXICITY; HEARTBURN; HUMAN; ILEOSTOMY; INTESTINE NECROSIS; INTESTINE PERFORATION; INTESTINE PREPARATION; IRON PILL GASTRITIS; IRON THERAPY; ISCHEMIC COLITIS; MALABSORPTION; MALACOPLAKIA; MESENTERIC VEIN THROMBOSIS; MUCOSA INFLAMMATION; MUCOSAL NECROSIS; NAUSEA AND VOMITING; NONCARDIAC CHEST PAIN; ODYNOPHAGIA; OROPHARYNGEAL MUCOSITIS; PEPTIC ULCER; PILL ESOPHAGITIS; PRIORITY JOURNAL; PROCTITIS; RETROSTERNAL PAIN; REVIEW; SEPSIS; SIGMOID; SLOUGHING ESOPHAGITIS; SQUAMOUS EPITHELIUM; STOMACH EROSION; STOMACH HEMORRHAGE; STOMACH ULCER; THORAX PAIN; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL (TOPIC); COLON ABSORPTION; DERMATITIS; DIFFERENTIAL DIAGNOSIS; ENDOCRINE DISEASE; ESOPHAGUS ULCER; GASTROINTESTINAL TRACT; HEPATITIS; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; LONG TERM EXPOSURE; LOWER ESOPHAGUS SPHINCTER; MEDICATION ASSOCIATED GASTROINTESTINAL TRACT LESION; MITOSIS INHIBITION; NEPHRITIS; PATIENT EDUCATION; PH; POTASSIUM BLOOD LEVEL; PROSTAGLANDIN SYNTHESIS; REFLUX ESOPHAGITIS; STOMACH DISEASE; UVEITIS;

COX; CYCLOOXYGENASE; MMF; MYCOPHENOLATE MOFETIL; NONSTEROIDAL ANTI-INFLAMMATORY DRUG; NSAID;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CATHARTICS; COLCHICINE; CONTRACEPTIVES, ORAL; DIURETICS; ERGOTAMINE; ESOPHAGITIS; HUMANS; IMIDAZOLES; INTESTINAL DISEASES; ION EXCHANGE RESINS; IRON; LAXATIVES; MYCOPHENOLIC ACID; STOMACH DISEASES; TETRAZOLES;

EID: 84890483257     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2013.08.027     Document Type: Article

References (68)

1. B. Witkop Paul Ehrlich and his Magic bullets - revisited Proc Am Philos Soc 143 1999 540 557
2. Foundation THKF. United States: Prescription Drugs. Available at: http://www.statehealthfacts.org. 2011. Accessed March 20, 2013.
3. Knapp DE, Robinson JI, Britt AL. Annual Adverse Drug Report 1995 by the FDA. Available at: http://www.fda.gov/cder/reports/annrep95.pdf. 1995. Accessed March 20, 2013.
4. M.P. Pusztaszeri, R.M. Genta, and B.L. Cryer Drug-induced injury in the gastrointestinal tract: clinical and pathologic considerations Nat Clin Pract Gastroenterol Hepatol 4 2007 442 453
5. V. Jain, and C.S. Pitchumoni Gastrointestinal side effects of prescription medications in the older adult J Clin Gastroenterol 43 2009 103 110
6. Z. Chen, J.R. Scudiere, and E. Montgomery Medication-induced upper gastrointestinal tract injury J Clin Pathol 62 2009 113 119
7. J.R. Parfitt, and D.K. Driman Pathological effects of drugs on the gastrointestinal tract: a review Hum Pathol 38 2007 527 536
8. N.S. Winstead, and R. Bulat Pill esophagitis Curr Treat Options Gastroenterol 7 2004 71 76
9. F.D. Lee Drug-related pathological lesions of the intestinal tract Histopathology 25 1994 303 308
10. H.W. Boyce Jr. Drug-induced esophageal damage: diseases of medical progress Gastrointest Endosc 47 1998 547 550
11. S.C. Abraham, J.H. Yardley, and T.T. Wu Erosive injury to the upper gastrointestinal tract in patients receiving iron medication: an underrecognized entity Am J Surg Pathol 23 1999 1241 1247
12. D.Y. Graham What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates Digestive diseases and sciences 47 2002 1665 1678
13. P.C. de Groen, D.F. Lubbe, and L.J. Hirsch Esophagitis associated with the use of alendronate N Engl J Med 335 1996 1016 1021
14. B.J. Gertz, S.D. Holland, and W.F. Kline Studies of the oral bioavailability of alendronate Clin Pharmacol Ther 58 1995 288 298
15. S.C. Abraham, M. Cruz-Correa, and L.A. Lee Alendronate-associated esophageal injury: pathologic and endoscopic features Mod Pathol 12 1999 1152 1157
16. J.K. Purdy, H.D. Appelman, and B.J. McKenna Sloughing esophagitis is associated with chronic debilitation and medications that injure the esophageal mucosa Mod Pathol 25 2012 767 775
17. S.W. Carmack, R. Vemulapalli, and S.J. Spechler Esophagitis dissecans superficialis ('sloughing esophagitis'): a clinicopathologic study of 12 cases Am J Surg Pathol 33 2009 1789 1794
18. R.H. Hruban, J.H. Yardley, and R.C. Donehower Taxol toxicity. Epithelial necrosis in the gastrointestinal tract associated with polymerized microtubule accumulation and mitotic arrest Cancer 63 1989 1944 1950
19. Z. Harel, S. Harel, and P.S. Shah Gastrointestinal adverse events with sodium polystyrene sulfonate (kayexalate) use: a systematic review Am J Med 126 2013 264 e9-e24
20. K.D. Lillemoe, J.L. Romolo, and S.R. Hamilton Intestinal necrosis due to sodium polystyrene (Kayexalate) in sorbitol enemas: clinical and experimental support for the hypothesis Surgery 101 1987 267 272
21. S.C. Abraham, B.S. Bhagavan, and L.A. Lee Upper gastrointestinal tract injury in patients receiving kayexalate (sodium polystyrene sulfonate) in sorbitol: clinical, endoscopic, and histopathologic findings Am J Surg Pathol 25 2001 637 644
22. M. Cozzolino, M.A. Rizzo, and A. Stucchi Sevelamer for hyperphosphataemia in kidney failure: controversy and perspective Ther Adv Chronic Dis 3 2012 59 68
23. C.A. Arnold, B.N. Limketkai, and T.-C. Liu Renvela crystals in the gastrointestinal (GI) tract: a new entity Mod Pathol 26 suppl 2 2013:144A.
24. R.E. Petras, W.R. Hart, and R.M. Bukowski Gastric epithelial atypia associated with hepatic arterial infusion chemotherapy. Its distinction from early gastric carcinoma Cancer 56 1985 745 750
25. L. Lim, P. Gibbs, and D. Yip A prospective evaluation of treatment with selective internal radiation therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy BMC Cancer 5 2005 132
26. C.A. Iacobuzio-Donahue, E.L. Lee, and S.C. Abraham Colchicine toxicity: distinct morphologic findings in gastrointestinal biopsies Am J Surg Pathol 25 2001 1067 1073
27. P.J. Fortun, and C.J. Hawkey Nonsteroidal antiinflammatory drugs and the small intestine Curr Opin Gastroenterol 21 2005 169 175
28. J. Lang, A.B. Price, and A.J. Levi Diaphragm disease: pathology of disease of the small intestine induced by non-steroidal anti-inflammatory drugs J Clin Pathol 41 1988 516 526
29. S. de Sanctis, T. Qureshi, and J.F. Stebbing Clinical and pathological overlap in nonsteroidal anti-inflammatory drug-related small bowel diaphragm disease and the neuromuscular and vascular hamartoma of the small bowel Am J Surg Pathol 25 2001 539 541
30. G. Cortina, S. Wren, and B. Armstrong Clinical and pathologic overlap in nonsteroidal anti-inflammatory drug-related small bowel diaphragm disease and the neuromuscular and vascular hamartoma of the small bowel Am J Surg Pathol 23 1999 1414 1417
31. G.A. FitzGerald, and C. Patrono The coxibs, selective inhibitors of cyclooxygenase-2 N Engl J Med 345 2001 433 442
32. K. von Bergmann, P. Laeis, and K. Puchler Olmesartan medoxomil: influence of age, renal and hepatic function on the pharmacokinetics of olmesartan medoxomil J Hypertension Suppl 19 2001 S33 S40
33. P. Laeis, K. Puchler, and W. Kirch The pharmacokinetic and metabolic profile of olmesartan medoxomil limits the risk of clinically relevant drug interaction J Hypertension Suppl 19 2001 S21 S32
34. J.M. Neutel Clinical studies of CS-866, the newest angiotensin II receptor antagonist Am J Cardiol 87 2001 37C 43C
35. A. Rubio-Tapia, M.L. Herman, and J.F. Ludvigsson Severe spruelike enteropathy associated with olmesartan Mayo Clin Proc 87 2012 732 738
36. R. Childers, G. Chow, and M. Fraig Education and imaging. Gastrointestinal: chronic cellcept-induced colitis J Gastroenterol Hepatol 26 2011 1214
37. M.K. Selbst, W.A. Ahrens, and M.E. Robert Spectrum of histologic changes in colonic biopsies in patients treated with mycophenolate mofetil Mod Pathol 22 2009 737 743
38. T. Nguyen, J.Y. Park, and J.R. Scudiere Mycophenolic acid (cellcept and myofortic) induced injury of the upper GI tract Am J Surg Pathol 33 2009 1355 1363
39. J.R. Parfitt, S. Jayakumar, and D.K. Driman Mycophenolate mofetil-related gastrointestinal mucosal injury: variable injury patterns, including graft-versus-host disease-like changes Am J Surg Pathol 32 2008 1367 1372
40. J.C. Papadimitriou, C.B. Cangro, and A. Lustberg Histologic features of mycophenolate mofetil-related colitis: a graft-versus-host disease-like pattern Int J Surg Pathol 11 2003 295 302
41. J. Weber Ipilimumab: controversies in its development, utility and autoimmune adverse events Cancer Immunol Immunother 58 2009 823 830
42. D.R. Minor, K. Chin, and M. Kashani-Sabet Infliximab in the treatment of anti-CTLA4 antibody (ipilimumab) induced immune-related colitis Cancer Biother Radiopharm 24 2009 321 325
43. H.J. Freeman Colitis associated with biological agents World J Gastroenterol 18 2012 1871 1874
44. D.A. Oble, M. Mino-Kenudson, and J. Goldsmith Alpha-CTLA-4 mAb-associated panenteritis: a histologic and immunohistochemical analysis Am J Surg Pathol 32 2008 1130 1137
45. A.A. Tarhini, and J.M. Kirkwood Tremelimumab (CP-675,206): a fully human anticytotoxic T lymphocyte-associated antigen 4 monoclonal antibody for treatment of patients with advanced cancers Expert Opin Biol Ther 8 2008 1583 1593
46. D. El Fassi, C.H. Nielsen, and J. Kjeldsen Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' disease Gut 57 2008 714 715
47. D.S. Ardelean, T. Gonska, and S. Wires Severe ulcerative colitis after rituximab therapy Pediatrics 126 2010 e243 e246
48. A. Adenis, L. Vanseymortier, and D. Foissey Bevacizumab and postponed suture leakages after surgery for ulcerative colitis and rectal cancer Gut 56 2007 734
49. M.S. Cappell Colonic toxicity of administered drugs and chemicals Am J Gastroenterol 99 2004 1175 1190
50. W.D. Biggar, L. Crawford, and C. Cardella Malakoplakia and immunosuppressive therapy. Reversal of clinical and leukocyte abnormalities after withdrawal of prednisone and azathioprine Am J Pathol 119 1985 5 11
51. S. Mpofu, C.M. Mpofu, and D. Hutchinson Steroids, non-steroidal anti-inflammatory drugs, and sigmoid diverticular abscess perforation in rheumatic conditions Ann Rheum Dis 63 2004 588 590
52. S.I. Gan, S. Urbanski, and S.P. Coderre Isolated visceral small artery fibromuscular hyperplasia-induced ischemic colitis mimicking inflammatory bowel disease Am J Gastroenterol 99 2004 2058 2062
53. A. Rashid, and S.R. Hamilton Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate (Kayexalate) in sorbitol: an underrecognized condition Am J Surg Pathol 21 1997 60 69
54. R.H. Oi The microscopic appearance of a sodium-potassium exchange resin in histologic sections Am J Clin Pathol 69 1978 359 361
55. O.A. Preventza, K. Lazarides, and M.D. Sawyer Ischemic colitis in young adults: a single-institution experience J Gastrointest Surg 5 2001 388 392
56. A.E. Stillman, M. Weinberg, and W.C. Mast Ischemic bowel disease attributable to ergot Gastroenterology 72 1977 1336 1337
57. B.L. Stein, E. Lamoureux, and M. Miller Glutaraldehyde-induced colitis Can J Surg 44 2001 113 116
58. D.K. Driman, and H.G. Preiksaitis Colorectal inflammation and increased cell proliferation associated with oral sodium phosphate bowel preparation solution Hum Pathol 29 1998 972 978
59. B.A. van Gorkom, E.G. de Vries, and A. Karrenbeld Review article: anthranoid laxatives and their potential carcinogenic effects Aliment Pharmacol Therapeut 13 1999 443 452
60. W.H. Percy, M.B. Burton, and F. Fallick A comparison in vitro of human and rabbit distal colonic muscle responses to inflammatory mediators Gastroenterology 99 1990 1324 1332
61. E. Leng-Peschlow Acceleration of large intestine transit time in rats by sennosides and related compounds J Pharm Pharmacol 38 1986 369 373
62. A. Van Hoestenberghe, P. De Witte, and K. Geboes The effect of rhein and rhein anthrone on intestinal fluid transport and on large intestine transit in germ-free rats Eur J Pharmacol 212 1992 121 123
63. D. Badiali, A. Marcheggiano, and F. Pallone Melanosis of the rectum in patients with chronic constipation Dis Colon Rectum 28 1985 241 245
64. G.S. Speare Melanosis coll; experimental observations on its production and elimination in twenty-three cases American journal of surgery 82 1951 631 637
65. J.R. Lambert, S.C. Luk, and K.P. Pritzker Brown bowel syndrome in Crohn's disease Arch Pathol Lab Med 104 1980 201 205
66. F.N. Ghadially, and E.W. Parry An electron-microscope and histochemical study of melanosis coli J Pathol Bacteriol 92 1966 313 317
67. J. Kunkel, S. Schmidt, and C. Loddenkemper Chronic diarrhea and melanosis coli caused by wellness drink Int J Colorect Dis 24 2009 595 596
68. D.S. Pardi, W.J. Tremaine, and H.J. Rothenberg Melanosis coli in inflammatory bowel disease J Clin Gastroenterol 26 1998 167 170